Integrated Molecular and Clinicopathologic Study of Tubo-Ovarian High-Grade Serous Carcinoma

被引：0
|
作者：
Santandrea, Giacomo [1 ]
Ceccarelli, Claudio [1 ]
Santini, Donatella [1 ]
Turchetti, Daniela [1 ]
Zamagni, Claudio [2 ]
Perrone, Anna Myriam [1 ]
De Iaco, Pierandrea [1 ]
De Leo, Antonio [3 ]
机构：
[1] Univ Bologna, S Orsola Malpighi Hosp, Bologna, Italy
[2] St Orsola Malpighi Acad Hosp Bologna, Bologna, Italy
[3] Univ Bologna, Bologna, Italy
来源：
MODERN PATHOLOGY | 2021年 / 34卷 / SUPPL 2期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
622
引用
收藏
页码：744 / 744
页数：1
相关论文
共 50 条
  • [1] Integrated Molecular and Clinicopathologic Study of Tubo-Ovarian High-Grade Serous Carcinoma
    Santandrea, Giacomo
    Ceccarelli, Claudio
    Santini, Donatella
    Turchetti, Daniela
    Zamagni, Claudio
    Perrone, Anna Myriam
    De Iaco, Pierandrea
    De Leo, Antonio
    [J]. LABORATORY INVESTIGATION, 2021, 101 (SUPPL 1) : 744 - 744
  • [2] High-grade serous carcinoma of tubo-ovarian origin: recent developments
    Singh, Naveena
    McCluggage, W. Glenn
    Gilks, C. Blake
    [J]. HISTOPATHOLOGY, 2017, 71 (03) : 339 - 356
  • [3] High-grade serous tubo-ovarian carcinoma presenting as paraneoplastic cerebellar degeneration
    Butt, E.
    Chadda, K. R.
    Tadross, J. A.
    Latimer, J.
    [J]. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2019, 126 : 95 - 95
  • [4] The Clinicopathological and Prognostic Values of Chemotherapy Response Score in Tubo-Ovarian High-Grade Serous Carcinoma
    Derogar, Roghaiyeh
    Mirzaei, Amirreza
    Sayyah-Melli, Manizheh
    Jafari-Shobeiri, Mehri
    Rahmani, Vahideh
    Vaezi, Maryam
    Dastranj Tabrizi, Ali
    Mostafa-Gharabaghi, Parvin
    [J]. INDIAN JOURNAL OF GYNECOLOGIC ONCOLOGY, 2024, 22 (02)
  • [5] SPL-108 mediates metastasis and chemoresistance in high-grade serous tubo-ovarian carcinoma
    Lara, Olivia
    Pereira, Luiza Doro
    Van Oudenhove, Elke
    Olvera, Narciso
    Dao, Fanny
    Hacker, Kari
    Levine, Douglas
    [J]. GYNECOLOGIC ONCOLOGY, 2021, 162 : S276 - S276
  • [6] Neoadjuvant Chemotherapy Modulates the Immune Microenvironment in Metastases of Tubo-Ovarian High-Grade Serous Carcinoma
    Bohm, Steffen
    Montfort, Anne
    Pearce, Oliver M. T.
    Topping, Joanne
    Chakravarty, Probir
    Everitt, Gemma L. A.
    Clear, Andrew
    McDermott, Jackie R.
    Ennis, Darren
    Dowe, Thomas
    Fitzpatrick, Amanda
    Brockbank, Elly C.
    Lawrence, Alexandra C.
    Jeyarajah, Arjun
    Faruqi, Asma Z.
    McNeish, Iain A.
    Singh, Naveena
    Lockley, Michelle
    Balkwill, Frances R.
    [J]. CLINICAL CANCER RESEARCH, 2016, 22 (12) : 3025 - 3036
  • [7] LRP1B-a prognostic marker in tubo-ovarian high-grade serous carcinoma
    Kolb, Svenja
    Hoffmann, Inga
    Monje, Nanna
    Dragomir, Mihnea P.
    Jank, Paul
    Bischoff, Philip
    Keunecke, Carlotta
    Pohl, Jonathan
    Kunze, Catarina Alisa
    Marchenko, Sofya
    Schmitt, Wolfgang D.
    Kulbe, Hagen
    Sers, Christine
    Sehouli, Jalid
    Braicu, Elena Ioana
    Denkert, Carsten
    Darb-Esfahani, Silvia
    Horst, David
    Sinn, Bruno V.
    Taube, Eliane T.
    [J]. HUMAN PATHOLOGY, 2023, 141 : 158 - 168
  • [8] Should All Cases of High-Grade Serous Ovarian, Tubal, and Primary Peritoneal Carcinomas Be Reclassified as Tubo-Ovarian Serous Carcinoma?
    Moss, Esther Louise
    Evans, Tim
    Pearmain, Philippa
    Askew, Sarah
    Singh, Kavita
    Chan, Kiong K.
    Ganesan, Raji
    Hirschowitz, Lynn
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (07) : 1201 - 1207
  • [9] TP53-wildtype High-Grade Serous Tubo-Ovarian Carcinomas
    Chui, M. Herman
    Soslow, Robert
    [J]. MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1029 - 1029
  • [10] TP53-wildtype High-Grade Serous Tubo-Ovarian Carcinomas
    Chui, M. Herman
    Soslow, Robert
    [J]. LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1029 - 1029
12345